Workstreams

MMIP is divided into six workstreams, each working towards achieving the outcome of an internationally recognised, attractive and thriving environment for medicines manufacturing. All of these workstreams are supported by overarching communications work and building the manufacturing community to ensure it speaks with one voice.

Regulatory Environment

The regulatory environment workstream is trying to maximise innovative processes by highlighting existing regulatory flexibility and the positive UK regulatory landscape to industry.

One of the ways it is doing this is by partnering with the Medicines and Healthcare Products Regulatory Agency (MHRA) to produce case studies on regulatory collaboration between medicines manufacturers and the MHRA Innovation Office. Further details on the MHRA Innovation Office and the case studies can be found here. 

Skills

The skills workstream aims to foster a sustainable medicines manufacturing workforce and appropriate skills to support the growth of medicines manufacturing in the UK.

Life Sciences 2030 Skills Strategy

At the start of 2020 MMIP supported the development and launch of the Life Sciences 2030 Skills Strategy in partnership with BIA, ABPI, Science Industry Partnership (SIP) and OLS. The Life Sciences 2030 Skills Strategy is another key milestone in delivering on the recommendation of the Life Sciences Industrial Strategy and subsequent sector deals. It sets out how, in the context of global markets, UK Life Sciences will attract, retain, train and develop the research, technical and manufacturing skills required. Workforce modelling indicated our sector has the potential to create approximately 133,000 sector jobs over the next ten years. In addition, the Cell and Gene Therapy Catapult 2019 skills demand report shows rapid growth in the cell and gene therapy industry, which is expected to continue, particularly in bioprocessing.

 

 

Advanced Therapies Manufacturing Taskforce

In 2016 MMIP set up the Advanced Therapies Manufacturing Taskforce in partnership with government to identify actions that the UK must consider taking to anchor manufacturing of advanced therapies in the UK. The resulting Advanced Therapies Manufacturing Taskforce Action Plan outlines a strategy on how the UK can become the global hub of advanced medicinal therapy manufacturing and ensure the long-term success of this industry in the UK.

One recommendation from the Action Plan was the creation and implementation of an end-to-end talent plan for the sector which encompasses integrated strategies to develop the talent pool at multiple entry-points, ranging from Manufacturing Technicians through to Post-doctoral and Professional levels. in 2017 the Gatsby Foundation, with its interest in technical training, funded work to investigate how to create a technician workforce. 

in 2018 Innovate UK invested £1.5m investment in Advanced Therapy Manufacturing Apprenticeships - see below for the report from the Gatsby funded work, Advanced Therapies Manufacturing Apprenticeships blog, Apprenticeship Guideline booklet from the event and Cell and Gene Therapy Catapult press release. Visit the Advanced Therapies Apprenticeship Community (ATAC) website for full details on the apprenticeship programmes.

In 2021, the Cell and Gene Therapy Catapult received £0.5m follow on funding from Innovate UK to continue growing apprenticeships in the sector - with over 150 apprentices from more than 40 organisations now benefiting from the programme.

Beyond apprenticeships, wider funding was received in 2020 when the Cell and Gene Therapy Catapult was awarded £4.7 million from BEIS through UKRI to develop workforce skills in advanced therapy and vaccine manufacturing. Driven by industry, this has been used to kick-start an Advanced Therapies Skills Training Network which includes a network of physical centres, starting with expansion of existing training facilities at National Horizons Centre, RoslinCT and University of Birmingham, plus develop an Online Training Platform to showcase existing learning programmes available, including e-learning, video, face to face, VR/IR and online training programmes. This will help build new career routes and develop targeted educational programmes and specific training content to support bringing in new people from across sectors, and upskill existing staff within organisations across the UK.

Fiscal environment

The fiscal environment workstream focuses on developing fiscal incentives to encourage a more competitive environment for medicines manufacturing in the UK.

This includes a briefing paper on the fiscal benefits of establishing and retaining medicine manufacture in the UK and a position paper on fiscal incentives

Technology and Innovation

The Technology and Innovation workstream seeks to understand and pursue the future needs of the medicines manufacturing industry.

Working with government agencies and academia, MMIP are identifying novel manufacturing technology areas, opportunities for their development and introduction in the UK and ways of facilitating this.

MMIP is putting resources towards a Medicines Manufacturing Innovation Centre, a unique, state-of-the-art facility offering transformative solutions in small molecule and fine chemical manufacturing.

Technology and Innovation Roadmap

During the second half of 2020, the Technology & Innovation workstream developed a roadmap, building on the MMIP mission, charting progress to date and describing how the continuing work of the MMIP will be organised under five ‘grand challenges’.

 

Advanced therapies manufacturing

The advanced therapies manufacturing workstream seeks to ensure delivery the recommendations of the Advanced Therapies Manufacturing Taskforce Action Plan which outlines a strategy on how the UK can become the global hub of advanced medicinal therapy manufacturing and ensure the long-term success of this industry in the UK. The transition of the Taskforce to "business as usual" was presented at the 2017 bioProcessUK Conference.

See the Taskforce press releases here 

One recommendation from the Action Plan was the creation and implementation of an end-to-end talent plan for the sector which encompasses integrated strategies to develop the talent pool at multiple entry-points, ranging from Manufacturing Technicians through to Post-doctoral and Professional levels. The Gatsby Foundation, with its interest in technical training, funded work to investigate how to create a technician workforce,  culminating in an AT Manufacturing Apprenticeship event at GSK Stevenage during National Apprenticeship week (#NAW18)! Potential and current employers joined apprentices, training providers, funders and accrediting bodies to explore the benefits of apprenticeships within AT Manufacturing, where information was provided on the latest developments in delivery from the Institute for Apprenticeships (IfA) and suitable apprenticeship programmes identified within the sector. Following the event, Innovate UK announced a £1.5m investment in AT Manufacturing Apprenticeships - see here for the report from the Gatsby funded work, Advanced Therapies Manufacturing Apprenticeships blog, Apprenticeship Guideline booklet from the event and Cell and Gene Therapy Catapult press release. Visit the Advanced Therapies Apprenticeship Community (ATAC) website for full details on the apprenticeship programmes. In 2021, when this investment ended, the Cell and Gene Therapy Catapult received £0.5m follow on funding from Innovate UK to continue growing apprenticeships in the sector - with over 150 apprentices from more than 40 organisations now benefiting from the programme.

Beyond apprenticeships, wider funding was received in 2020 when the Cell and Gene Therapy Catapult was awarded £4.7 million from BEIS through UKRI to develop workforce skills in advanced therapy and vaccine manufacturing. Driven by industry, this has been used to kick-start an Advanced Therapies Skills Training Network which includes a network of physical centres, starting with expansion of existing training facilities at National Horizons Centre, RoslinCT and University of Birmingham, plus develop an Online Training Platform to showcase existing learning programmes available, including e-learning, video, face to face, VR/IR and online training programmes. This will help build new career routes and develop targeted educational programmes and specific training content to support bringing in new people from across sectors, and upskill existing staff within organisations across the UK.